ReviewDrugs & aging2017

The Potential of β-Hydroxy-β-Methylbutyrate as a New Strategy for the Management of Sarcopenia and Sarcopenic Obesity.

Andrea P Rossi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.